Predict your next investment

OncoResponse company logo
Corporation
HEALTHCARE | Biotechnology
oncoresponseinc.com

See what CB Insights has to offer

Competitors

12

Business Relationships

3

Service Providers

1

OncoResponse Competitors & Alternatives

12 Competitors

OncoResponse has 12 competitors. OncoResponse's competitors are Immune-Onc Therapeutics, Fortis Therapeutics, Pionyr Immunotherapeutics, Neon Therapeutics, Epsilogen and more.

Latest Funding

Companies

Investment Stage

Total Funding

Mosaic
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

Location

3/30/2021

Series B - II

$81.32M

California

3/29/2021

Series A - II

$58M

California

6/23/2020

Corporate Minority

$345M

California

5/6/2020

Acq - P2P

$161M

Massachusetts

4/20/2020

Series A - III

$10.13M

United Kingdom

00/00/0000

Subscribe to see more

Subscribe to see more

$99M

Subscribe to see more

00/00/0000

Subscribe to see more

Subscribe to see more

$99M

Subscribe to see more

00/00/0000

Subscribe to see more

Subscribe to see more

$99M

Subscribe to see more

00/00/0000

Subscribe to see more

Subscribe to see more

$99M

Subscribe to see more

Latest Funding

3/30/2021

3/29/2021

6/23/2020

5/6/2020

4/20/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Investment Stage

Series B - II

Series A - II

Corporate Minority

Acq - P2P

Series A - III

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Total Funding

$81.32M

$58M

$345M

$161M

$10.13M

$99M

$99M

$99M

$99M

Mosaic

Location

California

California

California

Massachusetts

United Kingdom

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

OncoResponse Service Providers

1 Service Provider

OncoResponse has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Counsel

Service Provider

Associated Rounds

Provider Type

Counsel

Service Type

Partnership data by VentureSource

OncoResponse Partners & Customers

3 Partners and customers

OncoResponse has 3 strategic partners and customers. OncoResponse recently partnered with Just Biotherapeutics on January 1, 2020.

Date

Type

Business Partner

Country

News Snippet

Sources

1/16/2020

Vendor

Just Biotherapeutics

United States

Press Releases - News Center - OncoResponse JUST – EVOTEC BIOLOGICS WILL APPLY ITS FULLY INTEGRATED TECHNOLOGY PLATFORM IN ORDER TO ACCELERATE ONCORESPONSE’S LEAD PRODUCT CANDIDATE THROUGH DEVELOPMENT AND INTO THE CLINIC.

Hamburg , Germany -- Jan. 16 , 2020 -- Evotec SE today announced that its wholly-owned Seattle-based subsidiary company Just -- Evotec Biologics has established a collaborative relationship with OncoResponse , Inc. , a biotech company developing human antibodies as product candidates for multiple high value targets associated with immunosuppressive myeloid biology .

1

1/16/2020

Vendor

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

10/6/2015

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

1/16/2020

1/16/2020

10/6/2015

Type

Vendor

Vendor

Partner

Business Partner

Just Biotherapeutics

Country

United States

Subscribe to see more

Subscribe to see more

News Snippet

Press Releases - News Center - OncoResponse JUST – EVOTEC BIOLOGICS WILL APPLY ITS FULLY INTEGRATED TECHNOLOGY PLATFORM IN ORDER TO ACCELERATE ONCORESPONSE’S LEAD PRODUCT CANDIDATE THROUGH DEVELOPMENT AND INTO THE CLINIC.

Hamburg , Germany -- Jan. 16 , 2020 -- Evotec SE today announced that its wholly-owned Seattle-based subsidiary company Just -- Evotec Biologics has established a collaborative relationship with OncoResponse , Inc. , a biotech company developing human antibodies as product candidates for multiple high value targets associated with immunosuppressive myeloid biology .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.